NIH R01 · 2025
Opioid use disorder (OUD) is a life-threatening health condition affecting 7.6 million people in the U.S. Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, decrease mortality among patients with OUD by 50%. Emergency department (ED) visits for opioid overdose are an important opportunity to initiate MOUD, but buprenorphine is only prescribed to 1 in 12 patients visiting the ED for opioid overdose. Since 2015, at least 5 states have implemented laws requiring EDs treating patients for opioid overdose to offer MOUD induction or prescriptions, provide patients with information about MOUD, and/or provide “warm hand-offs”. State ED MOUD laws could increase MOUD…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.